-
After the sky-high price merger, more than 100,000 lawsuits, Bayer spent tens of billions of dollars out of trouble
Time of Update: 2020-05-30
MEDICAL NETWORK, May 28 (Xinhua) -- Bayer has reached an oral agreement with about 125,000 U.S plaintiffs to end all legal action against Monsanto's herbicide Roundup, Bloomberg reported on May 25 Ba
-
Japanese tourists snapping up Japanese medicine sadder than toilet lid
Time of Update: 2020-05-12
After a round trip, to Japan tourists the crazy rush to buy the Japanese toilet lid was originally from China, to Japan tourists cost not only than the domestic twice as much, but also bought
-
Global powder coating market value estimated at $15.7 billion by 2020
Time of Update: 2020-03-05
According to a new study, the global powder coating market is expected to be about $15.7 billion in 2020 and $21.4 billion by 2025, with a CAGR of 6.3% over the period The analysis points out that t
-
Essence pharmaceuticals terminates the development of two human monoclonal antibody products
Time of Update: 2020-02-20
In the evening of February 19th, the essence pharmaceutical announced that it signed the cooperation and authorization agreement with Kadmon Corporation and LLC in October 29, 2015 to cooperate in the
-
Lubinectedin, a new drug for small cell lung cancer, has been given priority by FDA
Time of Update: 2020-02-18
Compiling On February 17, pharmapar and jazz pharmaceuticals jointly announced that the FDA of the United States has accepted its application for priority review of new drug applications (NDA), seekin
-
The birth of a new name: 2019 coronavirus disease (covid-19
Time of Update: 2020-02-12
Novel coronavirus was officially named as the English coronavirus disease 2019 (COVID-19) (WHO), which was released by the director general of WHO yesterday "In accordance with the naming guidelines a
-
Cro industry ushers in the golden development period, these enterprises deserve attention
Time of Update: 2020-01-10
[pharmaceutical network market analysis] recently, Zhaoyan new drug released the notice of increase in performance in 2019, which said that it is expected to realize the non net profit deduction of 12
-
Essen Biotech and Tavotek Biopharmaceutical Company of the United States established a R&D strategic alliance
Time of Update: 2020-01-06
Yisheng biopharmaceutical Co., Ltd and tavotek biopharmaceutical Co., Ltd of the United States jointly announced that they have reached a strategic R & D alliance to jointly develop a multi-target imm
-
The results of a new round of national collection of varieties were announced, and two popular varieties were out of the market
Time of Update: 2019-12-30
[industry trends of pharmaceutical network] on December 29, the state organized the joint procurement office of centralized drug procurement and use released the national centralized drug procurement
-
China's multi field frontier research performance is active in the three major fields of chemistry and materials science with remarkable achievements
Time of Update: 2019-11-27
Guangming Daily, Beijing, Nov 26 (Reporter Yuan Yufei) on Nov 26, the "2019 research frontier release and seminar" jointly organized by the Academy of science and technology strategic consulting and R
-
Jotun adjusts U.S. business layout
Time of Update: 2019-11-14
jotun, , will make changes to its U.S business layout to ensure a fast and accurate service experience for local customers by improving its supply logistics network and product system the layout chan
-
2019 China Japan advanced medical and new drug R & D Summit Forum and the third round of achievement transformation Conference
Time of Update: 2019-11-05
"2019 China Japan advanced medical and new drug R & D summit and achievement transformation conference" will be held in Chengdu on November 10, 2019 (Registration No.9) The conference was jointly orga
-
An overview of the development of drugs for age-related macular degeneration (2
Time of Update: 2019-10-31
Author: the sea embraces all rivers In, we provide an overview of the AMD market and the status of marketed drugs In the future, there will be 300 million amd patients in the world and 40 million in C
-
[supermolecule] Rebek / Yu Yang, Professor of Shanghai University, published important research results on PNAs twice recently
Time of Update: 2019-10-07
Recently, the research team led by Professor Rebek and Professor Yu Yang of the center for supramolecular chemistry and catalysis of Shanghai University published two research papers on PNAs: Proceedi
-
Kidney cancer "immunity + target" first-line treatment! Combination therapy of mosadon and Pfizer keytruda + inlyta approved by EU
Time of Update: 2019-09-05
September 5, 2019 / BIOON / -- cancer immunotherapy giant Merck & Co recently announced that the European Commission (EC) has approved keytruda (coreda, common name: pembrolizumab, pabolizumab) combin
